H. D. Dorfman and B. Czerniak, Bone cancers, Cancer, vol.1, issue.S1, pp.203-210, 1995.
DOI : 10.1002/cncr.2820360925

E. Rosenberg, A. Cleton-jansen, and G. De-pinieux, Conventional osteosarcoma. In WHO Classification of Tumours of Soft Tissue and Bone, International Agency for Research on Cancer, pp.282-288, 2013.

G. Ottaviani and N. Jaffe, The Epidemiology of Osteosarcoma, Cancer Treat. Res, vol.152, pp.3-13, 2009.
DOI : 10.1007/978-1-4419-0284-9_1

V. Mialou, T. Philip, C. Kalifa, D. Perol, J. Gentet et al., Metastatic osteosarcoma at diagnosis, Cancer, vol.333, issue.5, pp.1100-1109, 2005.
DOI : 10.1007/978-3-642-82671-9_17
URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.21263/pdf

J. K. Anninga, H. Gelderblom, M. Fiocco, J. R. Kroep, A. H. Taminiau et al., Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?, European Journal of Cancer, vol.47, issue.16, pp.2431-2445, 2011.
DOI : 10.1016/j.ejca.2011.05.030

A. Longhi, C. Errani, M. De-paolis, M. Mercuri, and G. Bacci, Primary bone osteosarcoma in the pediatric age: State of the art, Cancer Treatment Reviews, vol.32, issue.6, pp.423-436, 2006.
DOI : 10.1016/j.ctrv.2006.05.005

S. Ferrari and E. Palmerini, Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma, Current Opinion in Oncology, vol.19, issue.4, pp.341-346, 2007.
DOI : 10.1097/CCO.0b013e328122d73f

D. C. Allison, S. C. Carney, E. R. Ahlmann, A. Hendifar, S. Chawla et al., A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era, Sarcoma, vol.12, issue.2, p.704872, 2012.
DOI : 10.1200/JCO.1994.12.2.423

A. Trama, L. Botta, R. Foschi, A. Ferrari, C. Stiller et al., Survival of European adolescents and young adults diagnosed with cancer in 2000???07: population-based data from EUROCARE-5, The Lancet Oncology, vol.17, issue.7, pp.896-906, 2016.
DOI : 10.1016/S1470-2045(16)00162-5

D. C. Dahlin and M. B. Coventry, Osteogenic Sarcoma, The Journal of Bone & Joint Surgery, vol.49, issue.1, pp.101-110, 1967.
DOI : 10.2106/00004623-196749010-00008

J. W. Martin, J. A. Squire, and M. Zielenska, The Genetics of Osteosarcoma, Sarcoma, vol.16, issue.1, 2012.
DOI : 10.1016/j.ejso.2009.01.011

J. M. Gillette, C. P. Gibbs, and S. M. Nielsen-preiss, Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma, In Vitro Cellular & Developmental Biology - Animal, vol.52, issue.3, pp.87-95, 2008.
DOI : 10.3109/10520296609116302

J. C. Brune, A. Tormin, M. C. Johansson, P. Rissler, O. Brosjö et al., Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts, International Journal of Cancer, vol.7, issue.2, pp.319-330, 2011.
DOI : 10.1016/j.ccr.2005.01.007
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.25697/pdf

C. A. Arndt and W. M. Crist, Common Musculoskeletal Tumors of Childhood and Adolescence, New England Journal of Medicine, vol.341, issue.5, pp.342-352, 1999.
DOI : 10.1056/NEJM199907293410507

F. Dujardin, M. B. Binh, C. Bouvier, A. Gomez-brouchet, F. Larousserie et al., MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone, Modern Pathology, vol.30, issue.5, pp.624-637, 2011.
DOI : 10.1097/01.pas.0000213282.20166.13
URL : https://hal.archives-ouvertes.fr/hal-00592167

J. V. Forment, A. Kaidi, and S. P. Jackson, Chromothripsis and cancer: causes and consequences of chromosome shattering, Nature Reviews Cancer, vol.131, issue.10, pp.663-670, 2012.
DOI : 10.1016/j.cell.2007.12.007

U. Basu-roy, C. Basilico, and A. Mansukhani, Perspectives on cancer stem cells in osteosarcoma, Cancer Letters, vol.338, issue.1, pp.158-167
DOI : 10.1016/j.canlet.2012.05.028

A. Abarrategi, J. Tornin, L. Martinez-cruzado, A. Hamilton, E. Martinez-campos et al., Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells Int, p.3631764, 2016.

A. Cleton-jansen, J. K. Anninga, I. H. Briaire-de-bruijn, S. Romeo, J. Oosting et al., Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways, Br. J. Cancer, vol.101, 1909.

F. Deschaseaux, C. Pontikoglou, and L. Sensébé, Bone regeneration: the stem/progenitor cells point of view, Journal of Cellular and Molecular Medicine, vol.47, issue.1-2, pp.103-115, 2010.
DOI : 10.3109/10428199909167382

W. Xiao, A. B. Mohseny, P. C. Hogendoorn, and A. Cleton-jansen, Mesenchymal stem cell transformation and sarcoma genesis, Clinical Sarcoma Research, vol.3, issue.1, p.10
DOI : 10.1038/nature09262
URL : https://doi.org/10.1186/2045-3329-3-10

J. Wang, P. Wu, P. C. Chen, -. Lee, C. Chen et al., Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells, STEM CELLS Translational Medicine, vol.356, issue.2 Pt A, pp.512-526
DOI : 10.1016/j.canlet.2014.01.017

J. Skoda, A. Nunukova, T. Loja, I. Zambo, J. Neradil et al., Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice, Tumor Biology, vol.25, issue.7, pp.9535-9548, 2016.
DOI : 10.1038/nbt1318

C. P. Gibbs, V. G. Kukekov, J. D. Reith, O. Tchigrinova, O. N. Suslov et al., Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis, Neoplasia, vol.7, issue.11, pp.967-976, 2005.
DOI : 10.1593/neo.05394

A. S. Adhikari, N. Agarwal, B. M. Wood, C. Porretta, B. Ruiz et al., CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance, Cancer Research, vol.70, issue.11, pp.4602-4612, 2010.
DOI : 10.1158/0008-5472.CAN-09-3463
URL : http://cancerres.aacrjournals.org/content/canres/70/11/4602.full.pdf

R. J. Buchsbaum and S. Oh, Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go, Cancers, vol.6, issue.12, 2016.
DOI : 10.3892/ijo.2011.1073
URL : http://www.mdpi.com/2072-6694/8/2/19/pdf

M. Dominici, K. Le-blanc, I. Mueller, I. Slaper-cortenbach, F. Marini et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, issue.4, pp.315-317, 2006.
DOI : 10.1080/14653240600855905

L. Melchor, S. Alvarez, E. Honrado, J. Palacios, A. Barroso et al., The Accumulation of Specific Amplifications Characterizes Two Different Genomic Pathways of Evolution of Familial Breast Tumors, Clinical Cancer Research, vol.11, issue.24, pp.8577-8584, 2005.
DOI : 10.1158/1078-0432.CCR-05-1278

A. Pandita, M. Zielenska, P. Thorner, J. Bayani, R. Godbout et al., Application of Comparative Genomic Hybridization, Spectral Karyotyping, and Microarray Analysis in the Identification of Subtype-Specific Patterns of Genomic Changes in Rhabdomyosarcoma, Neoplasia, vol.1, issue.3, pp.262-275, 1999.
DOI : 10.1038/sj.neo.7900036

M. Manandhar, K. S. Boulware, and R. D. Wood, The ERCC1 and ERCC4 (XPF) genes and gene products, Gene, vol.569, issue.2, pp.153-161, 2015.
DOI : 10.1016/j.gene.2015.06.026
URL : http://europepmc.org/articles/pmc4536074?pdf=render

J. Bayani, M. Zielenska, A. Pandita, K. Al-romaih, J. Karaskova et al., Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas, Genes, Chromosomes and Cancer, vol.130, issue.1, pp.7-16, 2003.
DOI : 10.1016/S0165-4608(01)00461-7

P. Avril, L. Le-nail, M. Á. Brennan, P. Rosset, G. De-pinieux et al., Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status, Journal of Bone Oncology, vol.5, issue.1, pp.5-14, 2016.
DOI : 10.1016/j.jbo.2015.11.002

J. Rousseau, V. Escriou, P. Perrot, G. Picarda, C. Charrier et al., Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models, Cancer Gene Therapy, vol.8, issue.6, pp.387-397, 2010.
DOI : 10.1002/jcb.21556

P. Perrot, J. Rousseau, A. Bouffaut, F. Rédini, E. Cassagnau et al., Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence, et al. Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence, p.10999, 2010.
DOI : 10.1371/journal.pone.0010999.s001
URL : https://hal.archives-ouvertes.fr/inserm-00667931

L. Pape and A. , Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model, PLoS ONE, vol.2012, issue.7
URL : https://hal.archives-ouvertes.fr/hal-00820340

E. I. Hauben, S. Weeden, J. Pringle, E. A. Van-marck, and P. C. Hogendoorn, Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup, European Journal of Cancer, vol.38, issue.9, pp.1218-1225, 2002.
DOI : 10.1016/S0959-8049(02)00037-0

A. Billiau, V. G. Edy, H. Heremans, J. Van-damme, J. Desmyter et al., Human Interferon: Mass Production in a Newly Established Cell Line, MG-63, Antimicrobial Agents and Chemotherapy, vol.12, issue.1, pp.11-15, 1977.
DOI : 10.1128/AAC.12.1.11

T. Mori, M. J. Yousefzadeh, M. Faridounnia, J. X. Chong, F. M. Hisama et al., variants identified in a cohort of patients with segmental progeroid syndromes, Human Mutation, vol.17, issue.2, pp.255-265, 2018.
DOI : 10.1111/j.1346-8138.1990.tb01677.x

M. Kovac, C. Blattmann, S. Ribi, J. Smida, N. S. Mueller et al., Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency, Nature Communications, vol.104, issue.1, pp.2015-8940
DOI : 10.1073/pnas.0710052104

M. Overholtzer, P. H. Rao, R. Favis, X. Lu, M. B. Elowitz et al., The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability, Proc. Natl. Acad. Sci. USA 2003, pp.11547-11552
DOI : 10.1038/ng1091

L. Mirabello, P. H. Rao, R. Favis, X. Lu, M. B. Elowitz et al., Germline TP53 Variants and Susceptibility to Osteosarcoma, JNCI: Journal of the National Cancer Institute, vol.12, issue.6, p.107, 2015.
DOI : 10.1016/S1470-2045(11)70119-X
URL : https://academic.oup.com/jnci/article-pdf/107/7/djv101/17314584/djv101.pdf

L. Wang, Y. Zhao, Y. Liu, K. Akiyama, C. Chen et al., IFN-?? and TNF-?? Synergistically Induce Mesenchymal Stem Cell Impairment and Tumorigenesis via NF??B Signaling, STEM CELLS, vol.91, issue.7, pp.1383-1395, 2013.
DOI : 10.1038/icb.2012.62
URL : http://onlinelibrary.wiley.com/doi/10.1002/stem.1388/pdf

J. S. Rhim, D. K. Park, P. Arnstein, R. J. Huebner, E. K. Weisburger et al., Transformation of human cells in culture by N-methyl-N???-nitro-N-nitrosoguanidine, Nature, vol.35, issue.5520, pp.751-753, 1975.
DOI : 10.1038/newbio230279a0

I. Pantic, Cancer stem cell hypotheses: Impact on modern molecular physiology and pharmacology research, Journal of Biosciences, vol.10, issue.5, pp.957-961, 2011.
DOI : 10.1186/bcr1855

M. Á. Brennan, A. Renaud, J. Amiaud, M. T. Rojewski, H. Schrezenmeier et al., Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate, Stem Cell Research & Therapy, vol.5, issue.5, p.114, 2014.
DOI : 10.1016/j.biomaterials.2014.08.018
URL : https://hal.archives-ouvertes.fr/inserm-01205389

D. Correa, R. A. Somoza, P. Lin, W. P. Schiemann, and A. Caplan, Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche, International Journal of Cancer, vol.9, issue.2, pp.417-427, 2016.
DOI : 10.1038/nrc2622
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.29709/pdf

A. I. Caplan, Mesenchymal Stem Cells: Time to Change the Name!, STEM CELLS Translational Medicine, vol.85, issue.2016, pp.1445-1451
DOI : 10.2106/00004623-200300002-00012

W. Xu, Z. Bian, Q. Fan, G. Li, and T. Tang, Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis, Cancer Letters, vol.281, issue.1, pp.32-41, 2009.
DOI : 10.1016/j.canlet.2009.02.022

E. L. Spaeth, J. L. Dembinski, A. K. Sasser, K. Watson, A. Klopp et al., Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression, PLoS ONE, vol.4, issue.4992, 2009.
DOI : 10.1371/journal.pone.0004992
URL : https://doi.org/10.1371/journal.pone.0004992

F. Xing, J. Saidou, and K. Watabe, Cancer associated fibroblasts (CAFs) in tumor microenvironment, Frontiers in Bioscience, vol.15, issue.1, pp.166-179, 2010.
DOI : 10.2741/3613
URL : http://europepmc.org/articles/pmc2905156?pdf=render

O. Blau, C. D. Baldus, W. Hofmann, G. Thiel, F. Nolte et al., Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts, Blood, vol.118, issue.20, pp.5583-5592, 2011.
DOI : 10.1182/blood-2011-03-343467

K. Kurose, K. Gilley, S. Matsumoto, P. H. Watson, X. Zhou et al., Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas, Nature Genetics, vol.155, issue.3, pp.355-357, 2002.
DOI : 10.1016/S0002-9440(10)65227-3

K. Kornicka, K. Marycz, K. A. Tomaszewski, M. Mar?-edziak, and A. Smieszek, The Effect of Age on Osteogenic and Adipogenic Differentiation Potential of Human Adipose Derived Stromal Stem Cells (hASCs) and the Impact of Stress Factors in the Course of the Differentiation Process, Oxidative Medicine and Cellular Longevity, vol.11, issue.2, p.309169, 2015.
DOI : 10.1089/scd.2005.14.92

A. Gomez-brouchet, C. Illac, J. Gilhodes, C. Bouvier, S. Aubert et al., CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial, OncoImmunology, vol.6, issue.9, p.1331193, 2017.
DOI : 10.1126/scitranslmed.3006504

M. Studeny, F. C. Marini, J. L. Dembinski, C. Zompetta, M. Cabreira-hansen et al., Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents, JNCI Journal of the National Cancer Institute, vol.20, issue.18, pp.1593-1603, 2004.
DOI : 10.1200/JCO.2002.02.082
URL : https://academic.oup.com/jnci/article-pdf/96/21/1593/7685850/djh299.pdf

K. Sun, C. Gong, H. Peng, H. Fang, J. Zhou et al., High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma, Molecular Medicine Reports, vol.16, issue.5, pp.6953-6957, 2017.
DOI : 10.3892/mmr.2017.7458

D. Aggoune, N. Sorel, M. Bonnet, J. Goujon, K. Tarte et al., Johnson-Ansa, H. Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis

M. Á. Brennan, A. Renaud, A. Gamblin, C. D-'arros, S. Nedellec et al., 3D cell culture and osteogenic differentiation of human bone marrow stromal cells plated onto jet-sprayed or electrospun micro-fiber scaffolds, Biomedical Materials, vol.10, issue.4, p.45019, 2015.
DOI : 10.1088/1748-6041/10/4/045019